Evidence map›Paper›PMID 29706637›Full record

ArticleEuropean journal of human genetics : EJHG2018

Tubulinopathies continued: refining the phenotypic spectrum associated with variants in TUBG1.

Stefanie Brock, Katrien Stouffs, Emmanuel Scalais, Marc D'Hooghe, Kathelijn Keymolen, Renzo Guerrini, William B Dobyns, Nataliya Di Donato, Anna C Jansen

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Novel loss of function mutation inFrontiers in cellular neuroscience · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 6 countries.

Stefanie BrockFaculty of Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
Katrien StouffsCentre for Medical Genetics, UZ Brussel, Brussels, Belgium.
Emmanuel ScalaisDivision of Pediatric Neurology, Department of Pediatrics, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
Marc D'HoogheDepartment of Neurology, Algemeen Ziekenhuis Sint-Jan, Bruges, Belgium.
Kathelijn KeymolenCentre for Medical Genetics, UZ Brussel, Brussels, Belgium.
Renzo GuerriniPediatric Neurology Unit and Laboratories, Children's Hospital A. Meyer, University of Florence, Florence, Italy.
William B DobynsCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-7681-2844
Nataliya Di DonatoInstitute for Clinical Genetics, TU Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0001-9439-4677
Anna C JansenNeurogenetics Research Group, Reproduction Genetics and Regenerative Medicine Research Cluster, Vrije Universiteit Brussel, Brussels, Belgium. anna.jansen@uzbrussel.be.ORCID http://orcid.org/0000-0002-3835-2824
Vrije Universiteit Brussel · BEAZ Sint-Jan · BECentre Hospitalier de Luxembourg · LUMeyer Children's Hospital · ITTechnische Universität Dresden · DEUniversitair Ziekenhuis Brussel · BEUniversity of Washington · US

Funding

De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
The Genetic Basis of Mid-Hindbrain MalformationsR01NS050375 · NINDS · UNIVERSITY OF MINNESOTA · PI DOBYNS, WILLIAM B. · 2005 to 2019
$9.9M
SIGNAL TRANSDUCTION PATHWAYS FOR NEURONAL MIGRATIONP01NS039404 · NINDS · UNIVERSITY OF CHICAGO · PI DOBYNS, WILLIAM B · 1999 to 2003
$4.9M
Megalencephaly and segmental brain overgrowth in humansR01NS092772 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2015 to 2019
$3.3M
NINDS NIH HHS P01 NS039404NINDS NIH HHS R01 NS050375NINDS NIH HHS R01 NS058721NINDS NIH HHS R01 NS092772
6 · The paper itself

Abstract

Tubulinopathies are a heterogeneous group of conditions with a wide spectrum of clinical severity resulting from variants in genes of the tubulin superfamily. Variants in TUBG1 have been described in three patients with posterior predominant pachygyria and microcephaly. We here report eight additional patients with four novel heterozygous variants in TUBG1 identified by next-generation sequencing (NGS) analysis. All had severe motor and cognitive impairment and all except one developed seizures in early life. The core imaging features included a pachygyric cortex with posterior to anterior gradient, enlarged lateral ventricles most pronounced over the posterior horns, and variable degrees of reduced white matter volume. Basal ganglia, corpus callosum, brainstem, and cerebellum were often normal, in contrast to patients with variants in other tubulin genes where these structures are frequently malformed. The imaging phenotype associated with variants in TUBG1 is therefore more in line with the phenotype resulting from variants in LIS1 (a.k.a. PAFAH1B1). This difference may, at least in part, be explained by gamma-tubulin's physiological function in microtubule nucleation, which differs from that of alpha and beta-tubulin.

Indexed as

Mutation, MissensePhenotypeAdolescentAdultBrainChildCognitive DysfunctionFemaleHeterozygoteHumansLissencephalyMaleMicrocephalySyndromeTubulinTUBG1 protein, humanTubulin

Identifiers

PMID29706637
PMCPMC6057922
OpenAlexW2803079609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.